Dipna Pharmachem Limited becomes Three Hundred and Eighty Ninth Company to get listed on BSE SME Platform
Dipna Pharmachem Limited is Gujarat based company whose registered office is at Ahmedabad.
Dipna Pharmachem Limited became the 389th company to get listed on the BSE SME Platform on September 08, 2022. Dipna Pharmachem Limited came out with an initial public offering of 40,02,000 equity shares of Rs.10 each for cash at a price of Rs. 38 per equity share, aggregating to Rs. 15.21 crore. The company successfully completed its public issue on August 30, 2022.
Dipna Pharmachem Limited is a Gujarat-based company whose registered office is in Ahmedabad. The company engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient, and chemical formulation products. The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other, etc.
Interactive Financial Services Limited was the lead manager of Dipna Pharmachem Limited.
So far, 150 companies have migrated to the main board. The 388 companies listed on the BSE SME Platform have raised Rs.4,201 crore from the market and the total market capitalization of 388 companies as on September 07, 2022, is Rs. 59,000 Crore. BSE is the market leader in this segment with a market share of 61 percent.
SEBI came out with detailed guidelines on May 18, 2010 for the launching of SME Exchange/Platform. BSE became the first stock exchange to get the approval from SEBI and launch its SME platform on 13th March 2012.
The response since the launch of this platform by BSE has been very positive to date.